Diabetes breakthrough as arthritis drug appears to stop condition developing

990     0
Type 1 diabetes, which is a lifelong autoimmune condition (Image: Getty Images)
Type 1 diabetes, which is a lifelong autoimmune condition (Image: Getty Images)

An existing drug has been discovered that appears to stop Type 1 diabetes from developing.

A world first trial has shown a rheumatoid arthritis drug can preserve the body’s own insulin production and suppress the progression of type 1 diabetes in people newly diagnosed. There are around 400,000 Brits living with type 1 diabetes which is a lifelong autoimmune condition occurring when the immune system goes rogue and kills the insulin-producing beta cells in the pancreas.

A drug called baricitinib has been found to inhibit a protein that is important in the immune system attack on the beta cells. Lead researcher Professor Thomas Kay, of global Type 1 charity JDRF, said: “Our trial has determined that baricitinib can preserve beta cell function and insulin production in people recently diagnosed with type 1 diabetes.

“This suggests that if given early enough baricitinib may allow people with type 1 diabetes to be significantly less dependent on insulin treatment.” People with type 1 diabetes must try to keep their blood glucose levels stable to avoid fluctuating between hyperglycaemia - very high - and hypoglycaemia - very low - blood glucose.

To do this, they must give themselves insulin either by injection or infusion through a pump many times a day just to stay alive. In the long-term unstable blood sugar levels can cause serious heart, nerve, eye, and kidney complications.

'I was so ashamed of diabetes that I injected myself under desk and became ill' dqxikeidqkikdinv'I was so ashamed of diabetes that I injected myself under desk and became ill'

The immune attack on beta cells happens gradually so younger people with type 1 may still have some beta cells that are able to make insulin. The trial, published in the New England Journal of Medicine, included 91 Australians aged 10 to 30 years who had been diagnosed in the previous 100 days.

Compared to placebo the daily dose of baricitinib resulted in stable C-peptide levels and sustained insulin production over 48 weeks. Baricitinib also led to improved time within insulin range. Rachel Connor, director at JDRF UK, said: “This is tremendously exciting news. For the past 100 years insulin has stood as the only treatment for type 1 diabetes.”

Martin Bagot

Diabetes

Read more similar news:

09.02.2023, 17:57 • News
'Put your fitness to the test with the latest tech, with no need to exercise'
19.02.2023, 10:00 • News
Cheap diabetes drug could 'halve' Alzheimer's risk, says new study
28.02.2023, 10:35 • News
Having good friends can slash your risk of 11 silent killers including cancer
11.01.2023, 14:30 • News
Urgent warning over silent killer that can affect teens - signs to watch out for
18.01.2023, 17:22 • News
Single dad 'completely lost' after boy, 9, dies just days after taken into care
19.01.2023, 09:23 • News
Diabetes warning over risk of sugary fruit juices - daily amount to drink
12.03.2023, 09:47 • News
'I thought my new husband had a cold - the real diagnosis is a death sentence'
14.03.2023, 13:38 • Sport
Hull FC's Cameron Scott on tackling diabetes and following Henry Slade's lead
17.03.2023, 23:36 • More
Pregnant Gogglebox star Ellie Warner shares health update during Channel 4 show
22.03.2023, 13:02 • More
Back pain and arthritis are top physical conditions Brits suffer from in silence